
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Endocrinol. , 26 February 2021
Sec. Thyroid Endocrinology
Volume 11 - 2020 | https://doi.org/10.3389/fendo.2020.613879
This article is part of the Research Topic Molecular Characterization of Thyroid Lesions in the Era of “Next Generation” Techniques View all 9 articles
A retraction of this article was approved in:
Retraction: SHCBP1 promotes papillary thyroid carcinoma carcinogenesis and progression through promoting formation of integrin and collagen and maintaining cell stemness
Citation: Geng H, Guo M, Xu W, Zang X, Wu T, Teng F, Wang Y, Liu X, Wang X, Sun Q and Liang J (2021) SHCBP1 Promotes Papillary Thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness. Front. Endocrinol. 11:613879. doi: 10.3389/fendo.2020.613879
Received: 19 November 2020; Accepted: 31 December 2020;
Published: 26 February 2021; Retracted: 13 February 2024.
Edited by:
Claudio Bellevicine, Federico II University Hospital, ItalyReviewed by:
Fabio Pagni, University of Milano-Bicocca, ItalyDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.